BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21568089)

  • 1. [Diffuse large cell lymphoma and colon adenocarcinoma in patient with Waldenström's macroglobulinaemia].
    Radojković M; Ristić S; Colović N; Cemerikić-Martinović V; Colović M
    Srp Arh Celok Lek; 2011; 139(1-2):95-8. PubMed ID: 21568089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of anaplastic large cell (Ki-1) lymphoma of B-cell phenotype, occurring in Waldenström's macroglobulinemia.
    Hamada T; Ishizuka H; Asai Y; Yamazaki T; Sawada U; Hasegawa H; Uchida T
    Pathol Int; 1999 Oct; 49(10):913-7. PubMed ID: 10571827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jh gene sequence analysis in a patient with Waldenström's macroglobulinaemia with subsequent development of immunoblastic lymphoma.
    Kondo H; Yumoto N; Mikata A; Date Y
    Clin Mol Pathol; 1995 Aug; 48(4):M215-8. PubMed ID: 16696010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare presentation of Waldenström's macroglobulinaemia requiring bilateral above-knee amputations: a case report.
    Deen R; Austin C; Bowden A; Bullen A
    J Med Case Rep; 2022 Nov; 16(1):417. PubMed ID: 36329532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenström's macroglobulinaemia.
    Weide R; Heymanns J; Köppler H
    Leuk Lymphoma; 1999 Dec; 36(1-2):203-6. PubMed ID: 10613467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia.
    Luigetti M; Frisullo G; Laurenti L; Conte A; Madia F; Profice P; Batocchi AP; Montano N; Tarnani M; Tonali PA; Sabatelli M
    J Neurol Sci; 2010 Apr; 291(1-2):89-91. PubMed ID: 20149395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study.
    Furman RR; Eradat HA; DiRienzo CG; Hofmeister CC; Hayman SR; Leonard JP; Coleman M; Advani R; Chanan-Khan A; Switzky J; Liao QM; Shah D; Jewell RC; Lisby S; Lin TS
    Lancet Haematol; 2017 Jan; 4(1):e24-e34. PubMed ID: 27914971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
    Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
    Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signet-ring cells in a Waldenström's Macroglobulinaemia.
    Molero T; De La Iglesia S; Santana C; Lemes A; Matutes E
    Leuk Lymphoma; 1998 Dec; 32(1-2):175-7. PubMed ID: 10037013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of chylothorax and direct pleura involvement in a case of Waldenström's macroglobulinaemia.
    Poisson J; Aregui A; Darnige L; Maley K; Gisselbrecht M
    Age Ageing; 2014 Jul; 43(4):581-3. PubMed ID: 24855112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkylating agents for Waldenstrom's macroglobulinaemia.
    Yang K; Tan J; Wu T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006719. PubMed ID: 19160296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review.
    Buske C; Sadullah S; Kastritis E; Tedeschi A; García-Sanz R; Bolkun L; Leleu X; Willenbacher W; Hájek R; Minnema MC; Cheng M; Bilotti E; Graef T; Dimopoulos MA;
    Lancet Haematol; 2018 Jul; 5(7):e299-e309. PubMed ID: 29958569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: spontaneous resolution upon cessation of fludarabine.
    Lim Z; Cassells R; Giles A; Cheow HK; Mir N
    Leuk Lymphoma; 2007 Aug; 48(8):1638-40. PubMed ID: 17701599
    [No Abstract]   [Full Text] [Related]  

  • 14. Waldenström's macroglobulinaemia terminating in acute myeloid leukaemia: report of a case and review of the literature.
    Majumdar G; Slater NG
    Leuk Lymphoma; 1993 Apr; 9(6):513-6. PubMed ID: 8339053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long survival after splenic immunoblastic transformation of Waldenström's macroglobulinaemia.
    Winter AJ; Obeid D; Jones EL
    Br J Haematol; 1995 Oct; 91(2):412-4. PubMed ID: 8547084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: renal lymphoma in a patient with Waldenstrom's macroglobulinaemia.
    Clifton AG; Baily GG
    Clin Radiol; 1991 Apr; 43(4):285-6. PubMed ID: 1902765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
    Pilon AF; Rhee PS; Messner LV
    Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin lesions in Waldenström's macroglobulinaemia. Characterization of the cellular infiltrate.
    Bergroth V; Reitamo S; Konttinen YT; Wegelius O
    Acta Med Scand; 1981; 209(1-2):129-31. PubMed ID: 6782837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.